Dashboard
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 7.21%
- Poor long term growth as Net Sales has grown by an annual rate of 9.10% over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 8.44 times
Flat results in Sep 25
Underperformed the market in the last 1 year
Stock DNA
Industrial Manufacturing
INR 45 Cr (Micro Cap)
23.00
31
0.00%
0.73
7.76%
1.75
Total Returns (Price + Dividend) 
Cranex for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Cranex Stock Evaluation Reflects Mixed Signals Amid Market Volatility
Cranex, a key player in the industrial manufacturing sector, has experienced a shift in its market evaluation driven by a combination of technical indicators, valuation metrics, financial trends, and quality assessments. Despite recent market volatility and subdued financial performance, the stock’s technical outlook shows signs of cautious optimism, while fundamental challenges continue to temper investor enthusiasm.
Read More
Cranex Sees Revision in Market Evaluation Amidst Challenging Financial Trends
Cranex, a microcap player in the industrial manufacturing sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical performance. The stock's recent assessment highlights a cautious outlook amid subdued operational metrics and persistent market underperformance.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
15-Nov-2025 | Source : BSEPlease find the attached Newspaper Publication of Un-Audited Financial Results (Standalone and Consolidated) of the Company for the Second Quarter ended on 30th September 2025.
Board Meeting Outcome for THE MEETING OF BOARD OF DIRECTORS HELD ON THURSDAY NOVEMBER 13TH 2025.
13-Nov-2025 | Source : BSEPlease find the attached Outcome of the Board Meeting held today i.e. Thursday 13th November 2025.
Submission Of Un-Audited Financial Results Of The Company For The Quarter Ended On 30Th September 2025 Pursuant To Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
13-Nov-2025 | Source : BSEPlease find the attached Unaudited Financial Results (Standalone and Consolidated) of the Company for the Second Quarter ended on 30th September 2025.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 0 FIIs
Piyush Agrawal (39.47%)
Hitesh Ramji Javeri (2.62%)
47.34%
Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY
YoY Growth in quarter ended Sep 2025 is 1.06% vs -10.91% in Sep 2024
YoY Growth in quarter ended Sep 2025 is -5.71% vs 79.49% in Sep 2024
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 0.90% vs -6.93% in Sep 2024
Growth in half year ended Sep 2025 is 0.00% vs 69.81% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'24
YoY Growth in nine months ended Dec 2024 is -19.12% vs 62.11% in Dec 2023
YoY Growth in nine months ended Dec 2024 is 57.14% vs 142.31% in Dec 2023
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -17.02% vs 50.10% in Mar 2024
YoY Growth in year ended Mar 2025 is 30.00% vs 167.86% in Mar 2024







